Status:
TERMINATED
Supplementation of Vitamin D in Patients With Type 2 Diabetes and Hypertension
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Collaborating Sponsors:
Federal University of Rio Grande do Sul
Conditions:
Hypertension
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
In patients with type 2 diabetes, the effects on blood pressure of vitamin D has been shown to be variable. Thus, the goal of this proposal is to evaluate the effect of vitamin D supplementation in pa...
Eligibility Criteria
Inclusion
- type 2 diabetes
- hypovitaminosis D
- hypertension
Exclusion
- pregnant or lactating
- patients using vitamin D supplementation
- using drugs that interfere on vitamin D metabolism (corticosteroids, anticonvulsants)
- illicit drug use
- diseases such as chronic renal failure (serum creatinine greater than 2.0 mg/dl)
- liver cirrhosis
- alcoholism
- dementia
- malignant disease that compromises the 5-year survival,
- digestive tract (malabsorption) diseases
- BMI\> 40 kg / m2
Key Trial Info
Start Date :
October 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT02204527
Start Date
October 1 2015
End Date
December 1 2016
Last Update
January 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HCPA, Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90035903